Literature DB >> 17698703

Patterns of atrophy differ among specific subtypes of mild cognitive impairment.

Jennifer L Whitwell1, Ronald C Petersen, Selamawit Negash, Stephen D Weigand, Kejal Kantarci, Robert J Ivnik, David S Knopman, Bradley F Boeve, Glenn E Smith, Clifford R Jack.   

Abstract

BACKGROUND: In most patients, mild cognitive impairment (MCI) represents the clinically evident prodromal phase of dementia. This is most well established in amnestic MCI, which is most commonly a precursor to Alzheimer disease (AD). It follows, however, that subjects with MCI who have impairment in nonmemory domains may progress to non-AD degenerative dementias.
OBJECTIVE: To investigate patterns of cerebral atrophy associated with specific subtypes of MCI.
DESIGN: Case-control study.
SETTING: Community-based sample at a tertiary referral center. PATIENTS: One hundred forty-five subjects with MCI and 145 age- and sex-matched cognitively normal control subjects. Mild cognitive impairment was classified as amnestic, single cognitive domain; amnestic, multiple domain; nonamnestic, single domain; and nonamnestic, multiple domain. Subjects with nonamnestic single-domain MCI were classified into language, attention/executive, and visuospatial subgroups on the basis of specific cognitive impairment. MAIN OUTCOME MEASURE: Patterns of gray matter loss in the MCI groups compared with control subjects, assessed using voxel-based morphometry.
RESULTS: Subjects in the amnestic single- and multiple-domain groups showed loss in the medial and inferior temporal lobes compared with control subjects, and those in the multiple-domain group also had involvement of the posterior temporal lobe, parietal association cortex, and posterior cingulate. Subjects in the nonamnestic single-domain group with language impairment showed loss in the left anterior inferior temporal lobe. The group with attention/executive deficits showed loss in the basal forebrain and hypothalamus. No coherent patterns of loss were observed in the other subgroups.
CONCLUSIONS: The pattern of atrophy in the amnestic MCI groups is consistent with the concept that MCI in most of these subjects represents prodromal AD. However, the varying patterns in the language and attention/executive subgroups suggest that these subjects may have a different underlying disorder.

Entities:  

Mesh:

Year:  2007        PMID: 17698703      PMCID: PMC2735186          DOI: 10.1001/archneur.64.8.1130

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  30 in total

Review 1.  Voxel-based morphometry--the methods.

Authors:  J Ashburner; K J Friston
Journal:  Neuroimage       Date:  2000-06       Impact factor: 6.556

2.  Atypical and typical presentations of Alzheimer's disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases.

Authors:  C J Galton; K Patterson; J H Xuereb; J R Hodges
Journal:  Brain       Date:  2000-03       Impact factor: 13.501

3.  Staging of brain pathology related to sporadic Parkinson's disease.

Authors:  Heiko Braak; Kelly Del Tredici; Udo Rüb; Rob A I de Vos; Ernst N H Jansen Steur; Eva Braak
Journal:  Neurobiol Aging       Date:  2003 Mar-Apr       Impact factor: 4.673

4.  A voxel-based morphometry study of temporal lobe gray matter reductions in Alzheimer's disease.

Authors:  Geraldo F Busatto; Griselda E J Garrido; Osvaldo P Almeida; Claudio C Castro; Cândida H P Camargo; Carla G Cid; Carlos A Buchpiguel; Sergio Furuie; Cassio M Bottino
Journal:  Neurobiol Aging       Date:  2003 Mar-Apr       Impact factor: 4.673

5.  A voxel-based morphometry study of semantic dementia: relationship between temporal lobe atrophy and semantic memory.

Authors:  C J Mummery; K Patterson; C J Price; J Ashburner; R S Frackowiak; J R Hodges
Journal:  Ann Neurol       Date:  2000-01       Impact factor: 10.422

6.  Differential cortical atrophy in subgroups of mild cognitive impairment.

Authors:  Sandra Bell-McGinty; Oscar L Lopez; Carolyn Cidis Meltzer; Joelle M Scanlon; Ellen M Whyte; Steven T Dekosky; James T Becker
Journal:  Arch Neurol       Date:  2005-09

Review 7.  More attention must be paid: the neurobiology of attentional effort.

Authors:  Martin Sarter; William J Gehring; Rouba Kozak
Journal:  Brain Res Rev       Date:  2006-03-13

8.  Patterns of temporal lobe atrophy in semantic dementia and Alzheimer's disease.

Authors:  D Chan; N C Fox; R I Scahill; W R Crum; J L Whitwell; G Leschziner; A M Rossor; J M Stevens; L Cipolotti; M N Rossor
Journal:  Ann Neurol       Date:  2001-04       Impact factor: 10.422

9.  Early and widespread cholinergic losses differentiate dementia with Lewy bodies from Alzheimer disease.

Authors:  Pietro Tiraboschi; Larry A Hansen; Michael Alford; Annette Merdes; Eliezer Masliah; Leon J Thal; Jody Corey-Bloom
Journal:  Arch Gen Psychiatry       Date:  2002-10

10.  Mapping gray matter loss with voxel-based morphometry in mild cognitive impairment.

Authors:  Gaël Chételat; Béatrice Desgranges; Vincent De La Sayette; Fausto Viader; Francis Eustache; Jean-Claude Baron
Journal:  Neuroreport       Date:  2002-10-28       Impact factor: 1.837

View more
  78 in total

1.  Functional connectivity of the posterior hippocampus is more dominant as we age.

Authors:  Sonja Blum; Christian Habeck; Jason Steffener; Qolamreza Razlighi; Yaakov Stern
Journal:  Cogn Neurosci       Date:  2014-10-31       Impact factor: 3.065

2.  Modeling and Estimating Recall Processing Capacity: Sensitivity and Diagnostic Utility in Application to Mild Cognitive Impairment.

Authors:  Michael K Wenger; Selamawit Negash; Ronald C Petersen; Lyndsay Petersen
Journal:  J Math Psychol       Date:  2010-02-01       Impact factor: 2.223

3.  Relative capability of MR imaging and FDG PET to depict changes associated with prodromal and early Alzheimer disease.

Authors:  David S Karow; Linda K McEvoy; Christine Fennema-Notestine; Donald J Hagler; Robin G Jennings; James B Brewer; Carl K Hoh; Anders M Dale
Journal:  Radiology       Date:  2010-09       Impact factor: 11.105

4.  Gray matter volume and dual-task gait performance in mild cognitive impairment.

Authors:  Takehiko Doi; Helena M Blumen; Joe Verghese; Hiroyuki Shimada; Hyuma Makizako; Kota Tsutsumimoto; Ryo Hotta; Sho Nakakubo; Takao Suzuki
Journal:  Brain Imaging Behav       Date:  2017-06       Impact factor: 3.978

5.  Short-Term Memory Depends on Dissociable Medial Temporal Lobe Regions in Amnestic Mild Cognitive Impairment.

Authors:  Sandhitsu R Das; Lauren Mancuso; Ingrid R Olson; Steven E Arnold; David A Wolk
Journal:  Cereb Cortex       Date:  2015-02-27       Impact factor: 5.357

6.  Heterogeneity of structural and functional imaging patterns of advanced brain aging revealed via machine learning methods.

Authors:  Harini Eavani; Mohamad Habes; Theodore D Satterthwaite; Yang An; Meng-Kang Hsieh; Nicolas Honnorat; Guray Erus; Jimit Doshi; Luigi Ferrucci; Lori L Beason-Held; Susan M Resnick; Christos Davatzikos
Journal:  Neurobiol Aging       Date:  2018-06-15       Impact factor: 4.673

7.  Neuropsychiatric symptoms in mild cognitive impairment: differences by subtype and progression to dementia.

Authors:  Emily R Edwards; Adam P Spira; Deborah E Barnes; Kristine Yaffe
Journal:  Int J Geriatr Psychiatry       Date:  2009-07       Impact factor: 3.485

8.  The picture superiority effect in patients with Alzheimer's disease and mild cognitive impairment.

Authors:  Brandon A Ally; Carl A Gold; Andrew E Budson
Journal:  Neuropsychologia       Date:  2008-10-17       Impact factor: 3.139

9.  Alzheimer disease: postmortem neuropathologic correlates of antemortem 1H MR spectroscopy metabolite measurements.

Authors:  Kejal Kantarci; David S Knopman; Dennis W Dickson; Joseph E Parisi; Jennifer L Whitwell; Stephen D Weigand; Keith A Josephs; Bradley F Boeve; Ronald C Petersen; Clifford R Jack
Journal:  Radiology       Date:  2008-07       Impact factor: 11.105

10.  Differences in brain volume, hippocampal volume, cerebrovascular risk factors, and apolipoprotein E4 among mild cognitive impairment subtypes.

Authors:  Jing He; Sarah Farias; Oliver Martinez; Bruce Reed; Dan Mungas; Charles Decarli
Journal:  Arch Neurol       Date:  2009-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.